ライフサイエンスコーパス: hay fever

1 es were inversely associated with asthma and hay fever.

2 ated its 100th birthday for the treatment of hay fever.

3 ures on the incidence of asthma, eczema, and hay fever.

4 blood eosinophils from patients with ragweed hay fever.

5 arents had asthma, bronchitis, emphysema, or hay fever.

6 risk of asthma and a slightly lower risk of hay fever.

7 The patient was an 8-year-old boy with hay fever.

8 dhood asthma, except for one SNP shared with hay fever.

9 rns were then related to asthma, eczema, and hay fever.

10 s pollen are the number one cause of outdoor hay fever.

11 factors and pollen counts may play a role in hay fever.

12 nce that TRAP was associated with eczema and hay fever.

13 of climate on the US prevalence of childhood hay fever.

14 tigate associations with asthma, eczema, and hay fever.

15 for socio-demographics, comorbid asthma, and hay fever.

16 related exposures and symptoms of asthma and hay fever.

17 l BMI and GWG were not associated with AE or hay fever.

18 doctor-diagnosed asthma, 25.8% AE, and 4.6% hay fever.

19 (0.34; 0.23-0.51), eczema (0.43; 0.30-0.61), hay fever (0.39; 0.27-0.55), and food allergies (0.60; 0

20 2.10) for atopy, 1.04 (95%CI: 0.99-1.09) for hay fever, 0.96 (95%CI: 0.86-1.06) for any allergy.

21 (1.83; 1.58-2.13), asthma (1.31; 1.14-1.51), hay fever (1.57; 1.36-1.81), and food allergy (2.08; 1.7

22 [1.41-2.84]), AD/eczema (1.73 [1.17-2.56]), hay fever (1.93 [1.41-2.65]) and food allergies (2.69 [1

23 D/eczema (3.89 [1.34-11.32]) [corrected] and hay fever (2.46 [1.11-5.41]) were associated with even h

24 The summary OR for the risk of hay fever (22 studies) was 1.23, 95% confidence interval

25 gE test (29.9% vs 44.6%; P = .02) or current hay fever (3.3% vs 7.6%; P = .002).

26 for asthma, 17.1% (95% CI, 16.9%-17.3%) for hay fever, 4.2% (95% CI, 4.1%-4.3%) for food allergy, an

27 uding eczema (4.93; 1.18-20.62; P = .03) and hay fever (6.25; 1.70-22.96) but not asthma or food alle

28 ma (adjusted HR 1.17; 95% CI, 1.06-1.29) and hay fever (adjusted HR 1.56; 95% CI, 1.22-2.01).

29 atively associated with childhood asthma and hay fever (adjusted odds ratio [OR] per category increas

30 emisiifolia), the major cause of late summer hay fever (allergic rhinitis) in the United States and C

31 examined the causal effect of BMI on asthma, hay fever, allergic sensitization, serum total immunoglo

32 asonality depending on the country - namely 'hay fever', 'allergy' and 'pollen' - showing cultural di

33 between allergic conditions (asthma, atopy, hay fever and "any allergy") and risk of prostate cancer

34 e participants (77%) had physician-diagnosed hay fever and 65% of the participants had been tested po

35 Therapies directed against IgE can alleviate hay fever and allergic asthma.

36 For having both hay fever and asthma by age 7 years, the association wit

37 We examined the causal effect of smoking on hay fever and asthma by using the smoking-associated sin

38 Observational studies on smoking and risk of hay fever and asthma have shown inconsistent results.

39 ngs to the most potent allergens involved in hay fever and asthma.

40 re for atopic dermatitis, the farm effect on hay fever and atopic sensitization could not be complete

41 teristics, there is a link still missing for hay fever and atopy.

42 For doctor-diagnosed hay fever and current rhinitis symptoms, the protective

43 Parental hay fever and early exposure to D pteronyssinus allergen

44 Asthma, hay fever and eczema partly coexist because they share m

45 cs play a bigger role predisposing eczema to hay fever and eczema to asthma than environmental factor

46 arental atopy history, particularly maternal hay fever and paternal asthma were related to lower Treg

47 was seen in a cluster where both parents had hay fever and pollen allergy and that of NAR, 11.0%, in

48 rs and pollen counts on the US prevalence of hay fever and statewide variation in prevalence.

49 he initial manifestation with progression to hay fever and then asthma, there is yet no definitive pr

50 arents had asthma, bronchitis, emphysema, or hay fever and with increased peak expiratory flow labili

51 rted medical history of asthma and/or atopy (hay fever and/or eczema/urticaria) in a historical cohor

52 ds were tested for associations with asthma, hay fever, and atopy in quantitative and qualitative mul

53 cultivation) was protective against asthma, hay fever, and atopy.

54 implicated in the comorbidity of asthma plus hay fever, and confirmed nine known loci.

55 D with warts had even higher odds of asthma, hay fever, and food allergies than those with AD and no

56 uding asthma, atopic dermatitis (AD)/eczema, hay fever, and food allergies.

57 allergic disease, including asthma, eczema, hay fever, and food allergies.

58 ciated with concomitant diagnoses of asthma, hay fever, and food allergy and increased disease severi

59 Incorporation of diagnoses of asthma, hay fever, and food allergy improves PPV and specificity

60 in the United States, and history of asthma, hay fever, and food allergy, anemia was associated with

61 n the United States, ever history of asthma, hay fever, and food allergy, eczema was found to be asso

62 sthma, asthma exacerbation in the past year, hay fever, and food allergy.

63 Early IgE sensitization onset, parental hay fever, and higher exposure to mites were associated

64 ons between atopy/allergies, asthma, eczema, hay fever, and hives and childhood/adolescent leukemia,

65 s is observed among people reporting asthma, hay fever, and other allergic conditions; however, findi

66 in the past 12 months and history of asthma, hay fever, and other allergies.

67 ory diseases (asthma, bronchitis, emphysema, hay fever, and pneumonia) in 1,553 lung cancer patients

68 allergic symptoms in adults (wheeze, asthma, hay fever, and rhinitis).

69 aregiver-reported history of eczema, asthma, hay fever, and/or food allergy.

70 io [aOR], 0.68; 95% CI, 0.59-0.78; P< .001), hay fever (aOR, 0.43; 95% CI, 0.36-0.52; P< .001), atopi

71 ility rates of women with asthma, eczema, or hay fever are lower than those of women in the general p

72 The diseases of asthma, eczema and hay fever are typified by reactions to common allergens,

73 ed maternal and paternal asthma, eczema, and hay fever as cross-sectional predictors of childhood ast

74 rapy were also demonstrated in patients with hay fever, as an alternative to conventional subcutaneou

75 f this study was to investigate how parental hay fever, asthma, and eczema affect the risk of allergi

76 usal effect of infantile eczema on childhood hay fever, asthma, or both.

77 of having or having had allergic rhinitis or hay fever at follow-up.

78 or the appearance and subsequent increase in hay fever at that time is the combination of hygiene and

79 effect against atopic manifestations such as hay fever, atopic eczema, allergic sensitization, or ast

80 red to be associated with current asthma and hay fever but not eczema.

81 "Do you have any nasal allergies, including hay fever?" (defining allergic rhinitis) was given by 23

82 Allergic disorders, such as anaphylaxis, hay fever, eczema and asthma, now afflict roughly 25% of

83 of larger families with lower prevalences of hay fever, eczema and objective markers of allergic sens

84 Risk was inversely associated with asthma, hay fever, eczema, and "any allergy," significantly for

85 hma symptoms and does not reduce the risk of hay fever, eczema, and allergic sensitization.

86 to an increased risk of allergic symptoms of hay fever, eczema, and food allergy later in life.

87 The interviews also inquired about wheeze, hay fever, eczema, and food allergy.

88 easured at 7 years of age (asthma, wheezing, hay fever, eczema, atopy, and total IgE).

89 and the risk of allergies/atopies including hay fever, eczema, food allergy, positive skin prick tes

90 used data on 5 allergic conditions (allergy, hay fever, eczema, rhinitis, and itchy rash) and serum-s

91 E levels and a strong propensity for asthma; hay fever; eczema; and impaired lung function, also in c

92 for the treatment of seasonal allergies and hay fever, emerges from this methodology.

93 nds (P < 0.0001) were observed for reported 'hay fever ever' and 'eczema ever' with increasing number

94 s controlling for sociodemographics, asthma, hay fever, food allergies, and psychiatric and behaviora

95 zema: one with high probabilities of asthma, hay fever, food allergy, and multiple sleep symptoms and

96 on infantile eczema and childhood asthma and hay fever for 3778 pairs of 7-year-olds matched to their

97 confidence interval (CI): 2.20, 3.76), while hay fever had a significant protective effect (OR = 0.58

98 th eczema in 14 of 17 studies, asthma in 11, hay fever in 12, and food allergy in 12.

99 Before the first description of hay fever in 1870, there was very little awareness of al

100 The US prevalence of hay fever in childhood was 18.0% (95% CI, 17.7% to 18.2%

101 of asthma, wheezing, atopic eczema (AE), and hay fever in children during the first 7 years of life.

102 ema in infancy might have a causal effect on hay fever in children with and perhaps without asthma.

103 mpanied by an increase in atopy, asthma, and hay fever in these villages.

104 Hay fever increased 2-fold in the villages (3.0% vs 7.7%

105 Parental isolated hay fever increased the odds of AR (OR 2.2, 95% CI 1.6-3

106 , both overall and among asthma, eczema, and hay fever investigated separately, and childhood acute l

107 d (2) the link between eczema and asthma and hay fever is independent of shared early-life environmen

108 s reporting both wheeze and doctor-diagnosed hay fever (n = 1,310, 6%) and non-allergic wheeze as rep

109 -allergic wheeze as reporting wheeze but not hay fever (n = 3,939, 18%); men without wheeze were the

110 ed about prior doctors' diagnoses of asthma, hay fever/nasal allergies/allergic rhinitis, and eczema.

111 egative association between NHL and seasonal hay fever (odds ratio (OR) = 0.28, 95% confidence interv

112 t current vs never smokers had lower risk of hay fever (odds ratio (OR) = 0.68, 95% confidence interv

113 (odds ratio = 0.43, 95% CI: 0.21, 0.89) and hay fever (odds ratio = 0.50, 95% CI: 0.25, 1.00) with a

114 Hay fever (odds ratio = 0.74, 95% CI: 0.56, 0.96) and al

115 hma (odds ratio = 0.85, 95% CI: 0.61, 1.18), hay fever (odds ratio = 0.81, 95% CI: 0.62, 1.06), and e

116 For having hay fever only, the association with cosibling's eczema

117 as defined as self-reported doctor diagnosed hay fever or allergic upper respiratory symptoms.

118 rhinitis was defined as physician-diagnosed hay fever or allergy, the presence of symptoms in the pa

119 ma and decreased lung function, but not with hay fever or biomarkers of allergy.

120 oral/pharyngeal symptoms, in the context of hay fever or pollen sensitisation, which can be triggere

121 ex (OR 2.0 [95% CI, 1.1-3.6]), and childhood hay fever (OR 2.0 [95% CI, 1.0-4.0]) as risk factors for

122 eczema (OR = 0.74, 95% CI: 0.58, 0.96), and hay fever (OR = 0.55, 95% CI: 0.46, 0.66) examined separ

123 rent smokers showed a slightly lower risk of hay fever (OR = 0.958, 95% CI: 0.920, 0.998; P = 0.041),

124 Asthma, hay fever (or allergic rhinitis) and eczema (or atopic d

125 r G allele (OR, 0.98 [95% CI, 0.66-1.47]) or hay fever (OR, 1.11 [95% CI, 0.71-1.72]), nor with any o

126 Sensitization to CG1 was associated with hay fever (OR, 12.79; 95% CI, 6.84-23.90; P < .001).

127 oth asthma (OR, 3.60; 95% CI, 2.05-6.29) and hay fever (OR, 2.52; 95% CI, 1.38-4.61).

128 R=1.009; 95% CI: 1.004, 1.013), but not with hay fever (OR= 0.998; 95% CI: 0.994, 1.002) or allergic

129 ociated with any other allergic disease (for hay fever, OR 0.64, 95% CI 0.53-0.77, P = 2.5*10(-6) ).

130 amined the association between AACs (asthma, hay fever, or allergy) and CRC among white, African-Amer

131 sensitization or prior diagnoses of asthma, hay fever, or eczema in black and white pregnant women.

132 al, but not paternal, atopic status (asthma, hay fever, or eczema with or without sensitization) was

133 eczema) but was not associated with asthma, hay fever, or use of prescription medication.

134 1.97 [1.22-3.16], history of atopic disease (hay fever: OR: 5.50 [3.42-9.00] and atopic dermatitis: O

135 elf-reported doctor's diagnosis of asthma or hay fever; or lung function at 20 years of age.

136 AR, 11.0%, in a cluster where one parent had hay fever, pollen allergy, and eczema.

137 Hay fever prevalence was significantly lower with second

138 These findings have implications for hay fever prevention.

139 ergens is strongly associated with asthma or hay fever, respectively.

140 phthalate metabolites and allergic symptoms (hay fever, rhinitis, allergy, wheeze, asthma) and sensit

141 Parental hay fever seems to be the dominating hereditary risk fac

142 For hay fever, significantly decreased risks were evident wi

143 For asthma and hay fever, SPT (cutoff value at 3 mm) had a significantl

144 nd wheezing in offspring but not with AE and hay fever, suggesting that pathways may be nonallergic.

145 mary outcome was patient-reported changes in hay fever symptoms assessed by a visual analog scale.

146 Hay fever symptoms during the pollen season were reduced

147 ials found that allergen EPIT can ameliorate hay fever symptoms.

148 The immunotherapy group had reduced hay-fever symptoms, skin-test sensitivity to ragweed, an

149 villages had lower prevalences of asthma and hay fever than children from towns, and in the Phase II

150 SPT has a higher specificity for asthma and hay fever than sIgE without difference for sensitivity.

151 year prevalence of eczema with asthma and/or hay fever was 3.2% (95% CI, 2.8% to 3.3%).

152 The American data, however, suggest that hay fever was already common in 1960.

153 2.03; 1.20-3.46; P = .009) while history of hay fever was not associated with anemia (0.85; 0.62-1.1

154 ivalent fertility rate ratios for eczema and hay fever were 1.15 (95% CI: 1.13, 1.17) and 1.08 (95% C

155 fantile eczema on asthma in children without hay fever, which might be early transient wheeze, is unl

156 atopy ranged from 50% for eczema to 72% for hay fever, while the negative predictive value ranged fr

157 P = .04) and eczema (21.9% vs 14.8%) but not hay fever (white women: 17.5% vs black women: 15.7%, P =

158 A matched group of patients with hay fever who had not received immunotherapy was followe

159 iated with asthma, atopic sensitization, and hay fever with odds ratios ranging from 0.17 to 0.73.

160 ty rates among women with asthma, eczema, or hay fever with rates in women without these diagnoses.

161 ty rates among women with asthma, eczema, or hay fever with those in the general female population.